论文部分内容阅读
目的观察和评价凝结芽孢杆菌活菌片(商品名:爽舒宝)预防产褥期便秘的临床疗效。方法选取我院正常分娩(阴道分娩或剖宫产)的产妇200例,按随机数字表分为观察组和对照组,每组均为100例。观察组的100例产妇给予口服凝结芽孢杆菌活菌片,首次2.1 g,后1.05 g/次,3次/d,温水送服,疗程为14 d;对照组的100例产妇不服用任何微生态制剂药物。观察两组产妇便秘发生率和大便次数、大便量、大便性状等。结果观察组产妇便秘的发生率为15%,明显低于对照组的50%,差异有统计学意义(P<0.05);观察组产妇大便次数及大便量均明显多于对照组,大便性状明显比对照组有所改善,且无伴随症状。结论凝结芽孢杆菌活菌片预防产褥期便秘疗效显著,值得临床推广。
Objective To observe and evaluate the clinical efficacy of Bacillus coagulans liveable tablets (product name: Shuang Shuobao) in preventing postpartum constipation. Methods 200 cases of normal delivery in our hospital (vaginal delivery or cesarean section) were randomly divided into observation group and control group with 100 cases in each group. 100 maternal women in the observation group were given viable Bacillus coagulans oral tablets, the first 2.1 g, after 1.05 g / time, 3 times / d, warm water delivery service for 14 d; control group of 100 mothers did not take any micro-ecological Preparation of drugs. The incidences of constipation and stool frequency, stool volume and stool traits in the two groups were observed. Results The incidence of constipation in the observation group was 15%, which was significantly lower than that in the control group (P <0.05). The number of stools and stool in the observation group were significantly more than those in the control group Compared with the control group has improved, and no accompanying symptoms. Conclusion Bacillus coagulans viable tablets prevent postpartum constipation significant effect, worthy of clinical promotion.